Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0910-0284
ICR Reference No:
202001-0910-009
Status:
Historical Active
Previous ICR Reference No:
201801-0910-008
Agency/Subagency:
HHS/FDA
Agency Tracking No:
CVM
Title:
Records and Reports Concerning Experience with Approved New Animal Drugs
Type of Information Collection:
Revision of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
07/29/2020
Retrieve Notice of Action (NOA)
Date Received in OIRA:
01/16/2020
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
07/31/2023
36 Months From Approved
03/31/2021
Responses
10,937
0
12,418
Time Burden (Hours)
99,882
0
101,363
Cost Burden (Dollars)
0
0
0
Abstract:
This information collection supports FDA regulations regarding records and reports concerning experience with approved new animal drugs. Respondents to the collection are animal drug manufacturers with approved new animal drug applications (NADAs), abbreviated new animal drug applications (ANADAs), or conditionally approved new animal drug applications (CNADAs), as well as licensed commercial feed mills and licensed mixer-feeders. The reporting and recordkeeping elements implement public health protection provisions provided for in the Federal Food, Drug and Cosmetic.
Authorizing Statute(s):
US Code:
21 USC 301 et seq.
Name of Law: Federal Food, Drug, and Cosmetic Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
0910-AH51
Final or interim final rulemaking
85 FR 45505
07/29/2020
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
83 FR 6480
02/14/2018
30-day Notice:
Federal Register Citation:
Citation Date:
85 FR 45505
07/29/2020
Did the Agency receive public comments on this ICR?
Yes
Number of Information Collection (IC) in this ICR:
7
IC Title
Form No.
Form Name
Drug experience reports; advertisements and promotional labeling; distributor statements
2301
Transmittal of Periodic Reports and Promotional Material
Mandatory adverse event reporting
FDA 1932
Veterinary Adverse Drug Reaction, Lack of Effectiveness, Product Defect Report
Medicated feed reports
One time recordkeeping resulting from implementation of new requirements (New SOPs and training)
Recordkeeping requirements under 510.301 and 514.80
Request for waiver from electronic reporting requirement
Voluntary adverse event reporting
1932a
Veterinary Adverse Drug Reaction, Lack of Effectiveness
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
10,937
12,418
0
0
-1,481
0
Annual Time Burden (Hours)
99,882
101,363
0
0
-1,481
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
This rulemaking revises the information collection to require electronic reporting or the granting of a waiver from the requirement. We have updated our mandatory reporting element (IC element 1) to reflect estimates consistent with the final rule, which results in a decrease in both annual responses and burden hours in the amount of 1512. This is because the currently approved estimate was shown to be too high by the FRIA for the final rule. Ultimately, upon approval of the revision, the 270 responses and hours attributable to mandatory electronic reporting will be captured under OMB Control No. 0910-0645, FDA’s Adverse Event Reporting System (which administers our MedWatch Program), however the 1 request for waiver will be retained in this information collection. We have also added a one-time recordkeeping burden in the amount of 30 responses and 30 burden hours to reflect implementation of the new requirements, but we expect this burden to be realized upon the next renewal request for the information collection (currently expires March 31, 2021). Cumulatively, these changes reflect a total decrease of 1481 hours and 1481 responses annually.
Annual Cost to Federal Government:
$700,000
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
No
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Domini Bean 301 796-5733 domini.bean@fda.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
01/16/2020
An official website of the United States government
The .gov means it's official.
The site is secure.
